Beta-blockers, autoregulation, and experimental design.
- 1 March 1984
- journal article
- abstracts
- Published by Wolters Kluwer Health in Hypertension
- Vol. 6 (2_pt_1) , 140-144
- https://doi.org/10.1161/01.hyp.6.2.140
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Role of cardiac factors in the initial hypotensive action by beta-adrenoreceptor blocking agents.Hypertension, 1984
- Beta-blockers, autoregulation, and experimental design.Hypertension, 1984
- Short-term systemic hemodynamic adaptation to beta-adrenergic inhibition with atenolol in hypertensive patients.Hypertension, 1981
- THE PRESENT STATUS OF THE AUTOREGULATION THEORY OF THE PATHOGENESIS OF HYPERTENSIONClinical and Experimental Pharmacology and Physiology, 1980
- Baroreceptor-induced decrease in muscle blood flow upon propranolol administrationEuropean Journal of Pharmacology, 1978
- The essential action of propranolol in hypertensionThe American Journal of Medicine, 1976
- Antihypertensive and Hemodynamic Properties of the New Beta Adrenergic Blocking Agent TimololCirculation, 1973
- Cerebral Blood Flow Autoregulation and Graded HypercapniaEuropean Neurology, 1971
- Use of Propranolol (Inderal) in Treatment of HypertensionBMJ, 1964
- HYPERTENSION EXPLAINED BY STARLING'S THEORY OF CIRCULATORY HOMŒOSTASISThe Lancet, 1963